Episode 26. Management of Newly Diagnosed Hodgkin's Lymphoma
Blood Cancer Talks
00:00
Rathal and Echelon Trials in Standard of Care for Hachkel and Fauma
There are two main trials I think we should touch on briefly one is the Rathal trial of but adapted therapy that was published in 2016. The second is the echelon trial that substituted leomycin for BV or brentaxenab without in the anti-spy 30 antibody drug conjugate which was published in 2018. How do you think these two trials in first standard of care of upfront treatment for hachkel and fauma?
Transcript
Play full episode
